| Title |
Lead Author |
Journal/Reference |
| Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. (Full text) |
Krishnan KR |
Am J Psychiatry. 2003 Nov;160(11):2003-11. |
| Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. (Full text) |
Lanctot KL |
CMAJ. 2003 Sep 16;169(6):557-64. |
| Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment. (Full text) |
Petersen RC |
N Engl J Med. 2005 Apr 13; [Epub ahead of print] |
| Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease. (Full text) |
Geldmacher DS |
J Am Geriatr Soc. 2003 Jul;51(7):937-44. |
| Early intervention is key to successful management of Alzheimer disease. (Abstract) |
DeKosky S |
Alzheimer Dis Assoc Disord. 2003 Jul-Sep;17 Suppl 4:S99-104. |
| Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. (Full text) |
Salloway S |
Neurology. 2004 Aug 24;63(4):651-7. |
| The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease. (Full text) |
Holmes C |
Neurology. 2004 Jul 27;63(2):214-9. |
| A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. (Full text) |
Winblad B |
Neurology. 2001 Aug 14;57(3):489-95. |
| A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. (Full text) |
Mohs RC |
Neurology. 2001 Aug 14;57(3):481-8. |
| Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial. (Full text) |
Seltzer B |
Arch Neurol. 2004 Dec;61(12):1852-6. |
| Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study. (Full text) |
Tune L |
Am J Geriatr Psychiatry. 2003 Mar-Apr;11(2):169-77. |